Component

The human whole blood assay of cyclooxygenase activity

The human whole blood assay of cyclooxygenase activity. Species, exposure and limitations are retained in each linked claim.

3 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

Read recorded mechanisms Open recursive mind map

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. Measurement of the inhibitory potency of non-steroidal anti-inflammatory drugs on cyclooxygenase isoforms is strongly influenced by variations in experimental conditions, the concentration of protein in the assay medium being particularly important because these drugs are highly protein bound in vivo so that assays based on human whole blood provide the most suitable test system, and of the drugs investigated only meloxicam showed selectivity for cyclooxygenase-2 at therapeutically relevant concentrations while standard drugs such as naproxen inhibited both isoforms to an equal degree.

    The human whole blood assay of cyclooxygenase activity → The ratio of cyclooxygenase-1 to cyclooxygenase-2 inhibitory potency source_derived_draftungraded
    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/ibuprofen-research/9219317.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d3edafe44ec9bf9e15505ffebb96add5467f8874fe8b585ce3878c473f250714", "start_char": 0, "end_char": 1162, "text_sha256": "d3edafe44ec9bf9e15505ffebb96add5467f8874fe8b585ce3878c473f250714"}
    experimental_model
    Comparison of cyclooxygenase inhibitory potency across assay systems, using the human whole blood assay
    exposure
    Standard non-steroidal anti-inflammatory drugs compared at therapeutically relevant concentrations
    limitations
    Argues that the whole blood assay is the appropriate test because these drugs are highly protein bound. It reports conclusions about the class, with naproxen named rather than ibuprofen.
    nutrient_topic
    Ibuprofen research collection; topical membership is not evidence of a direct clinical effect, and the racemate is recorded separately from each of its two enantiomers. · Ibuprofen
    organism
    Human
    plain_language
    Measured in blood rather than in a tube of enzyme, the ordinary anti-inflammatories hit both enzymes about equally.
    primary_references
    [ibu-p9219317] Differentiating among nonsteroidal antiinflammatory drugs by pharmacokinetic and pharmacodynamic profiles. (1997). https://pubmed.ncbi.nlm.nih.gov/9219317/ DOI: 10.1016/s0049-0172(97)80050-9
    tissue_or_cell_type
    Whole blood

    Ibuprofen: the enantiomer that works, the one that was called inactive, the one-way chemistry that turns one into the other, and the targets that are not cyclooxygenase (2026-09-22) · lines 344–355

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Comparison of cyclooxygenase inhibitory potency across assay systems, using the human whole blood assay · source_derived_draft · unverified_draft

    ### ibu-no-selectivity-in-whole-blood Measurement of the inhibitory potency of non-steroidal anti-inflammatory drugs on cyclooxygenase isoforms is strongly influenced by variations in experimental conditions, the concentration of protein in the assay medium being particularly important because these drugs are highly protein bound in vivo so that assays based on human whole blood provide the most suitable test system, and of the drugs investigated only meloxicam showed selectivity for cyclooxygenase-2 at therapeutically relevant concentrations while standard drugs such as naproxen inhibited both isoforms to an equal degree. Condition category: normal nutrient_topic: Ibuprofen research collection; topical membership is not evidence of a direct clinical effect, and the racemate is recorded separately from each of its two enantiomers. plain_language: Measured in blood rather than in a tube of enzyme, the ordinary anti-inflammatories hit both enzymes about equally. organism: Human tissue_or_cell_type: Whole blood experimental_model: Comparison of cyclooxygenase inhibitory potency across assay systems, using the human whole blood assay limitations: Argues that the whole blood assay is the appropriate test because these drugs are highly protein bound. It reports conclusions about the class, with naproxen named rather than ibuprofen. exposure: Standard non-steroidal anti-inflammatory drugs compared at therapeutically relevant concentrations evidence_span: {"source_cache": "artifacts/ibuprofen-research/9219317.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d3edafe44ec9bf9e15505ffebb96add5467f8874fe8b585ce3878c473f250714", "start_char": 0, "end_char": 1162, "text_sha256": "d3edafe44ec9bf9e15505ffebb96add5467f8874fe8b585ce3878c473f250714"} [ibu-p9219317] Differentiating among nonsteroidal antiinflammatory drugs by pharmacokinetic and pharmacodynamic profiles. (1997). https://pubmed.ncbi.nlm.nih.gov/9219317/ DOI: 10.1016/s0049-0172(97)80050-9
    Complete structured claim and evidence

Where it participates (unsigned role)

  1. Incubation of human mononuclear cells with lipopolysaccharide induced a time-dependent increase in cyclooxygenase-2 protein of more than a hundredfold at 24 hours with increased prostaglandin E2 production, while cyclooxygenase-1 protein was present at time zero and not induced, and most non-steroidal anti-inflammatory drugs are more potent at inhibiting cyclooxygenase-1 than cyclooxygenase-2, with five experimental compounds showing greater selectivity for cyclooxygenase-2.

    Cyclooxygenase-1 (PTGS1) → Ibuprofen source_derived_draftungraded
    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/ibuprofen-research/8907587.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "99f3a26e6399b5f81c18859b9f62eafcd7aa6fc4e483d97a39e8c35c060a9d75", "start_char": 0, "end_char": 1101, "text_sha256": "99f3a26e6399b5f81c18859b9f62eafcd7aa6fc4e483d97a39e8c35c060a9d75"}
    experimental_model
    Lipopolysaccharide-challenged human whole blood with prostaglandin E2 and thromboxane B2 as isoform indices
    exposure
    Lipopolysaccharide induction of cyclooxygenase-2 with a single oral indomethacin dose ex vivo
    limitations
    Establishes the assay the other records rely on. Indomethacin rather than ibuprofen is the drug dosed here.
    nutrient_topic
    Ibuprofen research collection; topical membership is not evidence of a direct clinical effect, and the racemate is recorded separately from each of its two enantiomers. · Ibuprofen
    organism
    Human
    plain_language
    The first enzyme is always there and the second one appears when tissue is provoked; most of these drugs hit the first harder.
    primary_references
    [ibu-p8907587] A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors. (1996). https://pubmed.ncbi.nlm.nih.gov/8907587/ DOI: 10.1007/bf02265118
    tissue_or_cell_type
    Whole blood and mononuclear cells

    Ibuprofen: the enantiomer that works, the one that was called inactive, the one-way chemistry that turns one into the other, and the targets that are not cyclooxygenase (2026-09-22) · lines 357–368

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Lipopolysaccharide-challenged human whole blood with prostaglandin E2 and thromboxane B2 as isoform indices · source_derived_draft · unverified_draft

    ### ibu-most-nsaids-favour-cox1 Incubation of human mononuclear cells with lipopolysaccharide induced a time-dependent increase in cyclooxygenase-2 protein of more than a hundredfold at 24 hours with increased prostaglandin E2 production, while cyclooxygenase-1 protein was present at time zero and not induced, and most non-steroidal anti-inflammatory drugs are more potent at inhibiting cyclooxygenase-1 than cyclooxygenase-2, with five experimental compounds showing greater selectivity for cyclooxygenase-2. Condition category: normal nutrient_topic: Ibuprofen research collection; topical membership is not evidence of a direct clinical effect, and the racemate is recorded separately from each of its two enantiomers. plain_language: The first enzyme is always there and the second one appears when tissue is provoked; most of these drugs hit the first harder. organism: Human tissue_or_cell_type: Whole blood and mononuclear cells experimental_model: Lipopolysaccharide-challenged human whole blood with prostaglandin E2 and thromboxane B2 as isoform indices limitations: Establishes the assay the other records rely on. Indomethacin rather than ibuprofen is the drug dosed here. exposure: Lipopolysaccharide induction of cyclooxygenase-2 with a single oral indomethacin dose ex vivo evidence_span: {"source_cache": "artifacts/ibuprofen-research/8907587.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "99f3a26e6399b5f81c18859b9f62eafcd7aa6fc4e483d97a39e8c35c060a9d75", "start_char": 0, "end_char": 1101, "text_sha256": "99f3a26e6399b5f81c18859b9f62eafcd7aa6fc4e483d97a39e8c35c060a9d75"} [ibu-p8907587] A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors. (1996). https://pubmed.ncbi.nlm.nih.gov/8907587/ DOI: 10.1007/bf02265118
    Complete structured claim and evidence

  2. In vitro acetaminophen elicited a 4.4-fold selectivity toward cyclooxygenase-2 inhibition with half-maximal inhibitory concentrations of 113.7 micromolar for cyclooxygenase-1 and 25.8 micromolar for cyclooxygenase-2, following a single oral 1000 milligram dose maximal ex vivo inhibitions were 56% for cyclooxygenase-1 and 83% for cyclooxygenase-2, plasma concentrations remained above the in vitro cyclooxygenase-2 value for at least 5 hours, and ex vivo values compared favourably with in vitro ones; acetaminophen inhibited cyclooxygenase-2 by more than 80%, comparable to non-steroidal anti-inflammatory drugs and selective inhibitors, but the greater than 95% cyclooxygenase-1 blockade relevant for suppression of platelet function was not achieved, and in view of its substantial cyclooxygenase-2 inhibition the cardiovascular warnings defined for selective inhibitors should also be considered.

    Paracetamol → Cyclooxygenase-2 (PTGS2) source_derived_draftungraded
    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/paracetamol-research/17884974.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e2856e9fc1c319219fd3d3cb145f70bb1157f7ca0baa0221594c9583cf7ddc23", "start_char": 0, "end_char": 1857, "text_sha256": "e2856e9fc1c319219fd3d3cb145f70bb1157f7ca0baa0221594c9583cf7ddc23"}
    experimental_model
    Ex vivo and in vitro human whole blood cyclooxygenase assays in five volunteers given a single oral dose
    exposure
    1000 milligrams oral acetaminophen, with coagulation-induced thromboxane B2 and lipopolysaccharide-induced prostaglandin E2 as isoform indices
    limitations
    Measures both isoform indices in dosed people and relates them to plasma concentration. Five volunteers and a single dose.
    nutrient_topic
    Paracetamol research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from the metabolites NAPQI and AM404. · Paracetamol
    organism
    Human
    plain_language
    In people it blocks the second enzyme as hard as a proper anti-inflammatory does, and never blocks the first enough to touch platelets.
    primary_references
    [apap-p17884974] Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. (2008). https://pubmed.ncbi.nlm.nih.gov/17884974/ DOI: 10.1096/fj.07-8506com
    tissue_or_cell_type
    Whole blood

    Paracetamol: the enzyme it reduces rather than blocks, the isoform that turned out not to exist, the metabolite that carries the analgesia, and the metabolite that destroys the liver (2026-09-22) · lines 259–270

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Ex vivo and in vitro human whole blood cyclooxygenase assays in five volunteers given a single oral dose · source_derived_draft · unverified_draft

    ### apap-four-fold-cox2-selective-in-man In vitro acetaminophen elicited a 4.4-fold selectivity toward cyclooxygenase-2 inhibition with half-maximal inhibitory concentrations of 113.7 micromolar for cyclooxygenase-1 and 25.8 micromolar for cyclooxygenase-2, following a single oral 1000 milligram dose maximal ex vivo inhibitions were 56% for cyclooxygenase-1 and 83% for cyclooxygenase-2, plasma concentrations remained above the in vitro cyclooxygenase-2 value for at least 5 hours, and ex vivo values compared favourably with in vitro ones; acetaminophen inhibited cyclooxygenase-2 by more than 80%, comparable to non-steroidal anti-inflammatory drugs and selective inhibitors, but the greater than 95% cyclooxygenase-1 blockade relevant for suppression of platelet function was not achieved, and in view of its substantial cyclooxygenase-2 inhibition the cardiovascular warnings defined for selective inhibitors should also be considered. Condition category: normal nutrient_topic: Paracetamol research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from the metabolites NAPQI and AM404. plain_language: In people it blocks the second enzyme as hard as a proper anti-inflammatory does, and never blocks the first enough to touch platelets. organism: Human tissue_or_cell_type: Whole blood experimental_model: Ex vivo and in vitro human whole blood cyclooxygenase assays in five volunteers given a single oral dose limitations: Measures both isoform indices in dosed people and relates them to plasma concentration. Five volunteers and a single dose. exposure: 1000 milligrams oral acetaminophen, with coagulation-induced thromboxane B2 and lipopolysaccharide-induced prostaglandin E2 as isoform indices evidence_span: {"source_cache": "artifacts/paracetamol-research/17884974.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e2856e9fc1c319219fd3d3cb145f70bb1157f7ca0baa0221594c9583cf7ddc23", "start_char": 0, "end_char": 1857, "text_sha256": "e2856e9fc1c319219fd3d3cb145f70bb1157f7ca0baa0221594c9583cf7ddc23"} [apap-p17884974] Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. (2008). https://pubmed.ncbi.nlm.nih.gov/17884974/ DOI: 10.1096/fj.07-8506com
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.